Phasic characteristics of inspiratory crackles of bacterial and atypical pneumonia

Postgraduate Medical Journal

Volumn 84, Issue 994, 2008, Pages 432-436

  Norisue, Y ^a   Tokuda, Y ^b   Koizumi, M ^c   Kishaba, T ^c   Miyagi, S ^d  

^a UNIVERSITY OF HAWAII   (United States)

^b St Luke's Life Science Institute   (Japan)

^c Okinawa Chubu Hospital   (Japan)

^d Muribushi Project of Residency Program   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL RESPIRATORY SOUND; ADULT; ARTICLE; BACTERIAL PNEUMONIA; COMMUNITY HOSPITAL; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RALE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TEACHING HOSPITAL; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PNEUMONIA, BACTERIAL; RESPIRATORY SOUNDS; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; YOUNG ADULT;

EID: 53649086066     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.067389     Document Type: Article

References (25)

1. Murphy RL Jr, Holford SK, Knowler WC. Visual lung-sound characterization by timeexpanded wave-form analysis. N Engl J Med 1977;296:968-971.
2. Hoevers J, Loudon RG. Measuring crackles. Chest 1990;98:1240-3.
3. Sovijärvi AR, Dalmasso F, Vanderschoot J, et al. Definition of terms for applications of respiratory sounds. Eur Respir Rev 2000;10:597-610.
4. Nath A, Capel LH. Inspiratory crackles early and late. Thorax 1974;29:223-7.
5. Piirila P, Sovijarvi AR, Kaisla T, et al. Crackles in patients with fibrosing alveolitis, bronchiectasis, COPD, and heart failure. Chest 1991;99:1076-83.
6. Nath AR, Capel LH. Lung crackles in bronchiectasis. Thorax 1980;35:694-9.
7. al Jarad N, Davies SW, Logan-Sinclair R, et al. Lung crackle characteristics in patients with asbestosis, asbestos-related pleural disease and left ventricular failure using a time-expanded waveform analysis: a comparative study. Respir Med 1994;88:37-46.
8. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000;31:383-421.
9. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-72.
10. Lieberman D, Ben-Yaakov M, Lazarovich Z, et al. Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infection 1996;24:109-14.
11. Lieberman D, Porath A, Schlaeffer F, et al. Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest 1996;109:1243-9.
12. Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996;51:179-84.
13. Lieberman D, Schlaeffer F, Horowitz S, et al. Mycoplasma pneumoniae communityacquired pneumonia: a review of 101 hospitalized adult patients. Respiration 1996;63:261-6.
14. Piirila P, Changes in crackle characteristics during the clinical course of pneumonia. Chest 1992;102:176-83.
15. Kishimoto T, Matsushima T, Morikawa T, et al. [Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 3. Setting of serological criteria]. (In Japanese.) Kansenshogaku Zasshi 1999;73:457-66.
16. Kishimoto T, Kubota Y, Matsushima T. et al. [Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards]. (ln Japanese.) Kansenshogaku Zasshi 1996;70:830-9.
17. Arnold FW, Summersgill JT, Lajoie AS, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007;175:1086-93.
18. Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330:456.
19. Miyagi S, Auscultation of the lungs. Nihon-lji-Shimpo 1992;3550:140-1.
20. Heffren R, Pneumonia with special reference to pneumococcal lobar pneumonia. New York, The Commonwealth Fund 1939; 204.
21. Baseman JB, Reddy SP, Oallo SF. Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections. Am J Respir Crit Care Med 1996;154:S137-44.
22. Saldias PF, Cabrera TD. Solminihac LI, et al. [Predictive value of history and physical examination for the diagnosis of community-acquired pneumonia in adults.]. Rev Med Chil 2007;135:143-152.
23. Nir-Paz R, Michael-Gayego A, Ron M, et al. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin Microbiol Infect 2006;12:685-8
24. Baersma MF, Dirven K, van Dam AP, et al. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol 2005;43:2277-85.
25. Gaydos CA, Roblin PM, Hammerschlag MR. et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994;32:903-5.